Parkinson's Disease Trial, Not Yet Recruiting NCT07277205 Sponsor: Marmara University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT07277205
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are between 40 and 75 years old
  • People who have been diagnosed with idiopathic Parkinson's disease (a form of Parkinson's disease that arises on its own, without a known cause)
  • People whose Parkinson's medications have remained unchanged for at least the past month
  • People whose Parkinson's disease is at a mild to moderate stage, as measured by a standard scale called Hoehn and Yahr (stages I to III)
  • People who score at least 22 out of 30 on a standard thinking and memory test called the Montreal Cognitive Assessment (MoCA)
  • People who are assessed during the period when their Parkinson's medication is working well (known as the "on" phase)
  • People who do not have any hearing or vision impairments

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a neurological, heart-related, or bone and joint condition that could affect their ability to walk
  • People who have been diagnosed with another neurological condition, such as dementia or disease affecting the blood vessels of the brain
  • People who have a deep brain stimulation (DBS) device implanted (a device surgically placed in the brain to help manage Parkinson's symptoms)
  • People who have conditions affecting the blood vessels in their legs

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Marmara University
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
1 June 2027

Primary endpoints

Mini-BESTest Total Score; Semantic Verbal Fluency Test (Semantic Fluency, 60 seconds)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov